Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice by Arunkumar, G, McMahon, M, Pavot, V, Aramouni, M, Ioannou, A, Lambe, T, Gilbert, S, Krammer, F

SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting by Siegel, CA, Melmed, GY, McGovern, DP, Rai, V, Krammer, F, Rubin, DT, Abreu, MT, Dubinsky, MC

Cross-reactive and cross-neutralizing activity of human mumps antibodies against a novel mumps virus from bats. by Beaty, S, Nachbagauer, R, Hirsh, A, Vigant, F, Duehr, J, Azarm, K, Stelfox, A, Bowden, T, Duprex, W, Krammer, F, Lee, B

Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge by McMahon, M, Asthagiri Arunkumar, G, Liu, W-C, Stadlbauer, D, Albrecht, RA, Pavot, V, Aramouni, M, Lambe, T, Gilbert, SC, Krammer, F

ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19 by Kaplonek, P, Cizmeci, D, Kwatra, G, Izu, A, Lee, JS-L, Bertera, HL, Fischinger, S, Mann, C, Amanat, F, Wang, W, Koen, AL, Fairlie, L, Cutland, CL, Ahmed, K, Dheda, K, Barnabas, SL, Bhorat, QE, Briner, C, Krammer, F, Saphire, EO, Gilbert, SC, Lambe, T, Pollard, AJ, Nunes, M, Wuhrer, M, Lauffenburger, DA, Madhi, SA, Alter, G

Innovative vaccine approaches-a Keystone Symposia report by Cable, J, Rappuoli, R, Klemm, EJ, Kang, G, Mutreja, A, Wright, GJ, Pizza, M, Castro, SA, Hoffmann, JP, Alter, G, Carfi, A, Pollard, AJ, Krammer, F, Gupta, RK, Wagner, CE, Machado, V, Modjarrad, K, Corey, L, B Gilbert, P, Dougan, G, Lurie, N, Bjorkman, PJ, Chiu, C, Nemes, E, Gordon, SB, Steer, AC, Rudel, T, Blish, CA, Sandberg, JT, Brennan, K, Klugman, KP, Stuart, LM, Madhi, SA, Karp, CL